Efficacy of Testosterone Suppression with Sustained-Release Triptorelin in Advanced Prostate Cancer

ConclusionIn the large majority of patients, triptorelin SR formulations suppressed serum testosterone concentrations to even  <20  ng/dl. Testosterone should be routinely monitored in PC patients on ADT although further studies on the clinical benefit of very low testosterone levels and the target concentrations are still warranted.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research